ANTIGONIST COMBINATION THERAPY OF ALDOSTERONE EPOXY-STEROID AND ANGIOTENSIN II ANTAGONIST FOR THE TREATMENT OF CONGESTIVE CARDIAC FAILURE.

摘要

A COMBINATION THERAPY THAT INCLUDES A THERAPEUTICALLY EFFECTIVE AMOUNT OF AN EFFECTIVE ALDOSTERONE RECEIVER ANTAGONIST OF AN ANTIGONIST OF THE ANGIOTENSIN II RECEIVER ANTAGONIST FOR THE TREATMENT OF CIRCULATORY CIRCULAR CIRCULAR DISTRIBUTIONS, CARDINES, CARBON CIRCULAR DISCUSSIONS ASCITES. THE PREFERRED ANTAGONISTS OF THE ANGIOTENSIN II RECEIVER ARE THOSE COMPOUNDS THAT HAVE A HIGH POWER AND BIODISPONIBILITY AND THAT ARE CHARACTERIZED BY POSSESSING AN IMIDAZOL OR TRIAZOL GROUP JOINED TO A BIFENILMETILO OR PIRIDINIL. THE ANTAGONISTS OF THE ALDOSTERONE EPOXI RECEIVER ARE SPIROXAN STEROID COMPOUNDS OR THE PRESENCE OF AN EPOXI PORTION REPLACED IN 9 AL}, 11 AL}. A PREFERRED COMBINATION THERAPY INCLUDES THE ANGIOTENSIN II RECEIVER ANTAGONIST 5 TETRAZOL AND THE ALDOSTERONE EPOXIMEXRENONE RECEIVER ANTAGONIST.